Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 15.7B | 14.5B | 12.2B | 12.8B |
Cost of revenue | 9.7B | 8.6B | 8.5B | 8.0B |
Gross profit | 5.9B | 5.9B | 3.7B | 4.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | 453.9M | — |
Other operating expenses | 2.1B | 2.0B | 1.2B | -892.3M |
Operating income | 2.7B | 2.8B | 839.6M | 1.3B |
Non operating interest income | ||||
Income | — | — | 30.8M | — |
Expense | 298.3M | 301.9M | 373.7M | 429.4M |
Other income expense | — | — | — | — |
Pretax income | 2.4B | 2.9B | 710.1M | 928.8M |
Tax provision | 564.1M | 729M | 487.2M | 126.7M |
Net income | 1.8B | 2.2B | 222.9M | 802.1M |
Basic EPS | — | 0.5 | 0.0 | — |
Diluted EPS | — | 0.5 | 0.0 | — |
Basic average shares | — | 4.7B | 4.7B | — |
Diluted average shares | — | 4.7B | 4.7B | — |
EBITDA | 3.8B | 4.4B | 2.2B | 3.1B |
Net income from continuing op. | — | — | 710.1M | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |